Steward Partners Investment Advisory LLC grew its position in shares of UiPath Inc. (NYSE:PATH – Free Report) by 99.8% during ...
Zurcher Kantonalbank Zurich Cantonalbank grew its stake in UiPath Inc. (NYSE:PATH – Free Report) by 57.5% in the 4th quarter, ...
Q4 2025 Earnings Call Transcript March 12, 2025 UiPath Inc. beats earnings expectations. Reported EPS is $0.26, expectations ...
UiPath Inc (NYSE: PATH) stock declined on weak Q4 revenue and Q1 guidance. Needham analyst reiterated Hold. Deal delays and ...
UiPath's growth slows to a crawl as it chases agentic AI dream with Peak acquisition, and its stock falls sharply - SiliconANGLE ...
UiPath's Q4 results show margin improvements, but analyst cautions on AI transition and growth pressure, lowering price ...
UiPath Inc (PATH) reports robust Q4 2025 results with a 14% increase in ARR, despite facing geopolitical and economic headwinds.
In the biotech sphere, ARK ETFs continued to accumulate shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Intellia Therapeutics Inc (NASDAQ: NTLA ), with purchases of 67,787 and 194,844 shares, ...
Learn more about whether Manhattan Associates, Inc. or UiPath Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
NEW YORK (AP) — NEW YORK (AP) — UiPath Inc. (PATH) on Wednesday reported fiscal fourth-quarter net income of $51.8 million. The New York-based company said it had net income of 9 cents per share.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results